The Claim
In older adults with mild cognitive impairment, higher baseline plasma docosahexaenoic acid (DHA) concentrations are associated with a 33% reduction in the proportion of individuals progressing to worse clinical dementia ratings (CDR >0) after two years of B vitamin treatment, compared to a 59% progression rate in the placebo group, suggesting that DHA status determines the effectiveness of B vitamins in preventing clinical worsening.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older people with early memory problems, those with more DHA (a type of omega-3 fatty acid) in their blood seem to benefit more from B vitamin supplements — only 33% of them got worse over two years, compared to 59% of those who took a placebo. This suggests DHA levels might decide whether B vitamins help stop memory from getting worse.
See the scientific wording
In older adults with mild cognitive impairment, higher baseline plasma docosahexaenoic acid (DHA) concentrations are associated with a 33% reduction in the proportion of individuals progressing to worse clinical dementia ratings (CDR >0) after two years of B vitamin treatment, compared to 59% in placebo, suggesting DHA status determines whether B vitamins can prevent clinical worsening.
What the research says
1 studyIn older adults with early memory problems, B vitamins only helped slow decline if they already had high levels of DHA (a healthy fat found in fish). Without enough DHA, the vitamins didn’t help.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.